Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added; Melanoma, related topics: MedlinePlus Genetics, and Revision: v3.3.3 were removed from the page.
    Difference
    0.2%
    Check dated 2026-01-14T03:17:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Melanoma is added as the condition category and MedlinePlus Genetics is added as a related topic.
    Difference
    0.2%
    Check dated 2026-01-07T01:37:11.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    - The page no longer shows the 'Melanoma' condition and the 'MedlinePlus Genetics' related topics section.
    Difference
    0.2%
    Check dated 2025-12-31T00:34:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:07:56.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added as related topics, and publication descriptions were updated with revised wording. These are minor editorial updates to the study page.
    Difference
    0.3%
    Check dated 2025-11-25T11:36:28.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Removal of the government funding/operating-status notice at the top of the page. The study details and other content are unaffected.
    Difference
    0.4%
    Check dated 2025-11-18T07:17:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.